National Health Authority (NHA) has invited comments on the Consultation Paper on the Drug Registry. This intends to create a nationally recognized source of truth for information on various systems of medicine in the country. Union Health Ministry said the comments and feedback can be uploaded or emailed to <a href="mailto:abdm@nha.gov.in" target="_blank">abdm@nha.gov.in</a> till the 1st of May this year.<br />''<br />''Chief Executive Officer of National Health Authority Dr. R. S. Sharma said, through Drug Registry, Ayushman Bharat Digital Mission aims to provide a standardized, comprehensive set of verified data on all the approved drugs marketed in the country that would enable a more efficient regulatory process. He said, to enable inclusivity and widen the perspectives on the table, he urged all stakeholders to go through the shared consultation papers and provide their valuable feedback.<br />